StreetInsider.com News Articles

MaxCyte signs technology license deal with Genentech for cell therapy

Tue, 21 Jul 2026 08:05:27 -0400

MaxCyte, Inc. (NASDAQ: MXCT) announced a technology license partnership with Genentech, a member of the Roche Group, to support Genentech's cell therapy development programs, according to a press release dated July 21, 2026.

The agreement grants Genentech access to MaxCyte's ExPERT GTx platform and additional platform technologies spanning research, clinical development, and manufacturing workflows. The license is structured to support multiple programs and enables ex vivo cell engineering applications.

The partnership covers cell engineering workflows from early discovery through current Good Manufacturing Practice (cGMP) manufacturing.

"Cell therapy development increasingly requires technology partners that can support programs as they advance from research through development

MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development

Tue, 21 Jul 2026 08:05:00 -0400

Technology License Partnership provides Genentech access to MaxCyte’s portfolio of platform technologies across research, development, and manufacturing workflows

ROCKVILLE, Md., July 21, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced that it has entered into a technology license partnership with Genentech, a member of the Roche Group, to support the development of cell therapy programs.

The license provides Genentech with access to MaxCyte’s ExPERT GTx^® platform and additional platform technologies across select research, clinical development, and manufacturing

MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development

Tue, 21 Jul 2026 08:05:00 -0400

Technology License Partnership provides Genentech access to MaxCyte’s portfolio of platform technologies across research, development, and manufacturing workflows

The license provides Genentech with access to MaxCyte’s ExPERT GTx^® platform and additional platform technologies across select research, clinical development, and manufacturing

MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026

Wed, 15 Jul 2026 16:05:00 -0400

ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2026 after the U.S. market close on Wednesday, August 12^th, 2026. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.

Earnings Conference Call Details
Investors interested in listening to the conference call are required to register online. It is recommended to register at

MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026

Wed, 15 Jul 2026 16:05:00 -0400

Earnings Conference Call Details
Investors interested in listening to the conference call are required to register online. It is recommended to register at

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Johnston John Joseph

Mon, 22 Jun 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260622/26673514.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Johnston John Joseph

Mon, 22 Jun 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260622/26673514.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Hemrajani Rekha

Mon, 22 Jun 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260622/26673494.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Hemrajani Rekha

Mon, 22 Jun 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260622/26673494.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Erck Stanley C

Mon, 22 Jun 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260622/26673488.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Erck Stanley C

Mon, 22 Jun 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260622/26673488.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: DOUGLAS RICHARD

Mon, 22 Jun 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260622/26673474.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: DOUGLAS RICHARD

Mon, 22 Jun 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260622/26673474.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Collins Cynthia

Mon, 22 Jun 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260622/26673470.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Collins Cynthia

Mon, 22 Jun 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260622/26673470.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Brooke William W

Mon, 22 Jun 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260622/26673466.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Brooke William W

Mon, 22 Jun 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260622/26673466.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: BALTHROP PATRICK J

Mon, 22 Jun 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260622/26673459.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: BALTHROP PATRICK J

Mon, 22 Jun 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260622/26673459.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Al-Wakeel Yasir B.

Mon, 22 Jun 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260622/26673451.html

Form 4 MAXCYTE, INC. For: Jun 17 Filed by: Al-Wakeel Yasir B.

Mon, 22 Jun 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260622/26673451.html

Form 8-K MAXCYTE, INC. For: Jun 17

Wed, 17 Jun 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260617/26660782.html

Form 8-K MAXCYTE, INC. For: Jun 17

Wed, 17 Jun 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260617/26660782.html

Form 8-K MAXCYTE, INC. For: Jun 10

Tue, 16 Jun 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260616/26654403.html

Form 8-K MAXCYTE, INC. For: Jun 10

Tue, 16 Jun 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260616/26654403.html